Drug profile · INN
netilmicin sulfate
NETROMYCIN
netilmicin sulfate (NETROMYCIN) is a bacterial 70s ribosome inhibitor. Route of administration: injection. Current US regulatory status: approved.
Drug details — netilmicin sulfate
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
netilmicin sulfate (NETROMYCIN) is a bacterial 70s ribosome inhibitor. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Bacterial 70S ribosome inhibitor
Primary target: Bacterial 70S ribosome
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is netilmicin sulfate?
netilmicin sulfate (NETROMYCIN) is a bacterial 70s ribosome inhibitor. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for netilmicin sulfate?
NETROMYCIN is a marketed brand name for netilmicin sulfate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of netilmicin sulfate?
netilmicin sulfate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.